Current opinions on the role of apolipoprotein B in the clinical management of cardiovascular risk
Review of ApoB as a direct count of atherogenic particles and its superiority over cholesterol-based markers for cardiovascular risk assessment.
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
Future Cardiology
Jan 2025
Structured Methods
- Study Design
- Review
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (2025). Current opinions on the role of apolipoprotein B in the clinical management of cardiovascular risk. Future Cardiology.
Source
Publisher
Journal
Future Cardiology
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
